Choking-induced cardiac arrest unmasks a diagnosis of catecholaminergic polymorphic ventricular tachycardia.

Suppr

超能文献

作者信息

Roston Thomas M, AlAhmari Leenah, Krahn Andrew D, Sherwin Elizabeth, Sanatani Shubhayan

机构信息

King Saud University, Riyadh, Saudi Arabia.

University of British Columbia, Vancouver, Canada.

出版信息

HeartRhythm Case Rep. 2015 Aug 17;1(6):494-497. doi: 10.1016/j.hrcr.2015.08.007. eCollection 2015 Nov.

DOI:10.1016/j.hrcr.2015.08.007

PMID:28491614

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5419722/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c40/5419722/bcccb7cfe1cc/gr1.jpg

相似文献

Choking-induced cardiac arrest unmasks a diagnosis of catecholaminergic polymorphic ventricular tachycardia.

HeartRhythm Case Rep. 2015 Aug 17;1(6):494-497. doi: 10.1016/j.hrcr.2015.08.007. eCollection 2015 Nov.

Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.

Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.

Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.

J Med Case Rep. 2018 Oct 9;12(1):298. doi: 10.1186/s13256-018-1825-6.

Thoracoscopic Left Cardiac Sympathetic Denervation for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia and Recurrent Implantable Cardioverter-Defibrillator Shocks.

Korean J Thorac Cardiovasc Surg. 2015 Jun;48(3):220-4. doi: 10.5090/kjtcs.2015.48.3.220. Epub 2015 Jun 5.

Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.

Heart Rhythm. 2013 Nov;10(11):1671-5. doi: 10.1016/j.hrthm.2013.08.011. Epub 2013 Aug 13.

A Rare Case of RYR2 Mutation Causing Sudden Cardiac Arrest Due to Catecholaminergic Polymorphic Ventricular Tachycardia.

Cureus. 2021 Feb 18;13(2):e13417. doi: 10.7759/cureus.13417.

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Heart Rhythm. 2011 Jun;8(6):864-71. doi: 10.1016/j.hrthm.2011.01.048. Epub 2011 Feb 9.

Exercise Testing Using Sprint Protocol vs Bruce Protocol in Catecholaminergic Polymorphic Ventricular Tachycardia.

JACC Case Rep. 2022 Aug 3;4(15):996-1000. doi: 10.1016/j.jaccas.2022.06.003.

Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT).

Int J Cardiol Heart Vasc. 2022 May 27;41:101062. doi: 10.1016/j.ijcha.2022.101062. eCollection 2022 Aug.

Recurrent Cardiac Arrest With Negative Stress Test: An Unusual Presentation of Catecholaminergic Polymorphic Ventricular Tachycardia.

JACC Case Rep. 2020 Jul 15;2(8):1178-1181. doi: 10.1016/j.jaccas.2020.05.075. eCollection 2020 Jul.

本文引用的文献

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.

Circulation. 2015 Jun 23;131(25):2185-93. doi: 10.1161/CIRCULATIONAHA.115.015731. Epub 2015 May 27.

Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.

Circ Arrhythm Electrophysiol. 2015 Jun;8(3):633-42. doi: 10.1161/CIRCEP.114.002217. Epub 2015 Feb 24.

HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Heart Rhythm. 2013 Dec;10(12):1932-63. doi: 10.1016/j.hrthm.2013.05.014. Epub 2013 Aug 30.

Complex atrial arrhythmias as first manifestation of catecholaminergic polymorphic ventricular tachycardia: an unusual course in a patient with a new mutation in ryanodine receptor type 2 gene.

Cardiol Young. 2014 Aug;24(4):741-4. doi: 10.1017/S1047951113001091. Epub 2013 Aug 28.

Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):579-87. doi: 10.1161/CIRCEP.113.000170. Epub 2013 May 11.

The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.

Europace. 2012 Sep;14(9):1344-51. doi: 10.1093/europace/eus031. Epub 2012 Mar 1.

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.

Europace. 2012 Feb;14(2):175-83. doi: 10.1093/europace/eur277. Epub 2011 Sep 4.

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

J Am Coll Cardiol. 2011 May 31;57(22):2244-54. doi: 10.1016/j.jacc.2011.01.026.

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Heart Rhythm. 2011 Jun;8(6):864-71. doi: 10.1016/j.hrthm.2011.01.048. Epub 2011 Feb 9.

Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.

J Cardiovasc Electrophysiol. 2008 Dec;19(12):1319-21. doi: 10.1111/j.1540-8167.2008.01211.x. Epub 2008 Jun 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验